Top 5 Small Cap Stocks To Own Right Now

On Thursday, our Under the Radar Movers newsletter suggested small cap dry bulk shipping Diana Shipping Inc (NYSE: DSX) as a short/bearish position:

“If you’ve been keeping tabs on the market’s more obscure goings-on, then you’ll know shipping stocks have been going nuts since the middle of last week. That rally — largely a short-covering rally — has run its course though, and the sellers and profit-takers are digging in again. We’ll jump on that budding pullback for a quick score. Diana Shipping is our best bet to do that, in percentage terms. It could fall another 20% before finding its next technical floor.”

“This won’t be a very long-held trade, no matter what.”

Our Under the Radar Movers newsletter has a detailed discussion about Diana Shipping’s technical chart along with a potential shorting strategy: 

Top 5 Small Cap Stocks To Own Right Now: Petroquest Energy Inc(PQ)

Advisors’ Opinion:

  • [By Ethan Ryder]

    News headlines about Petroquest Energy (NYSE:PQ) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Petroquest Energy earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave news stories about the energy company an impact score of 47.638327846877 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Top 5 Small Cap Stocks To Own Right Now: Sky-mobi Limited(MOBI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Mobius (CURRENCY:MOBI) traded 12.4% lower against the US dollar during the 24 hour period ending at 17:00 PM E.T. on September 25th. One Mobius token can now be bought for approximately $0.0265 or 0.00000414 BTC on major cryptocurrency exchanges including Gate.io, Kucoin, BitMart and GOPAX. Over the last week, Mobius has traded up 8.8% against the US dollar. Mobius has a market cap of $10.22 million and approximately $69,762.00 worth of Mobius was traded on exchanges in the last day.

  • [By Logan Wallace]

    Media coverage about Sky-mobi (NASDAQ:MOBI) has trended somewhat positive this week, according to Accern Sentiment. The research group ranks the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Sky-mobi earned a news impact score of 0.06 on Accern’s scale. Accern also assigned news stories about the software maker an impact score of 45.6853785900783 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

  • [By Ethan Ryder]

    Mobius (CURRENCY:MOBI) traded 1.2% lower against the dollar during the 1-day period ending at 14:00 PM E.T. on August 21st. In the last week, Mobius has traded down 1.1% against the dollar. One Mobius token can now be bought for about $0.0291 or 0.00000452 BTC on popular cryptocurrency exchanges including GOPAX, BitMart, Gate.io and Stellar Decentralized Exchange. Mobius has a total market capitalization of $11.23 million and approximately $78,528.00 worth of Mobius was traded on exchanges in the last 24 hours.

Top 5 Small Cap Stocks To Own Right Now: ATA Inc.(ATAI)

Advisors’ Opinion:

  • [By Paul Ausick]

    ATA Inc. (NASDAQ: ATAI) traded down about 14% Monday to set a new 52-week low of $0.82, based on revalued shares that closed at $0.72 on Friday but traded up about 250% on Monday at $2.53. Volume was more than 200 times the daily average of around 42,000. You’re on your own here to figure this one out.

Top 5 Small Cap Stocks To Own Right Now: Achillion Pharmaceuticals Inc.(ACHN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Achillion Pharmaceuticals (NASDAQ:ACHN) – Research analysts at B. Riley reduced their FY2018 EPS estimates for shares of Achillion Pharmaceuticals in a research note issued to investors on Wednesday, May 2nd. B. Riley analyst M. Kumar now anticipates that the biopharmaceutical company will earn ($0.58) per share for the year, down from their previous estimate of ($0.55). B. Riley has a “Neutral” rating and a $3.50 price objective on the stock. B. Riley also issued estimates for Achillion Pharmaceuticals’ FY2019 earnings at ($0.64) EPS, FY2020 earnings at ($0.71) EPS, FY2021 earnings at ($0.70) EPS and FY2022 earnings at ($0.84) EPS.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    News articles about Achillion Pharmaceuticals (NASDAQ:ACHN) have trended somewhat positive this week, Accern Sentiment reports. The research firm ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Achillion Pharmaceuticals earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave news articles about the biopharmaceutical company an impact score of 46.941587509483 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Logan Wallace]

    BidaskClub upgraded shares of Achillion Pharmaceuticals (NASDAQ:ACHN) from a strong sell rating to a sell rating in a research report sent to investors on Tuesday morning.

  • [By Stephan Byrd]

    Achillion Pharmaceuticals (NASDAQ:ACHN) has been given an average recommendation of “Hold” by the nine brokerages that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating on the company. The average 12 month price target among analysts that have covered the stock in the last year is $5.20.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Small Cap Stocks To Own Right Now: China Metro-Rural Holdings Limited(CNR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Canadian National Railway (NYSE:CNI) (TSE:CNR) – Analysts at Seaport Global Securities issued their Q1 2019 EPS estimates for shares of Canadian National Railway in a research note issued to investors on Wednesday, January 30th. Seaport Global Securities analyst M. Levin expects that the transportation company will earn $0.96 per share for the quarter. Seaport Global Securities also issued estimates for Canadian National Railway’s Q2 2019 earnings at $1.26 EPS, Q3 2019 earnings at $1.27 EPS and Q4 2019 earnings at $1.26 EPS.

  • [By Max Byerly]

    Press coverage about Canadian National Railway (NYSE:CNI) (TSE:CNR) has been trending somewhat positive on Thursday, according to Accern Sentiment Analysis. Accern identifies positive and negative press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Canadian National Railway earned a coverage optimism score of 0.15 on Accern’s scale. Accern also gave media coverage about the transportation company an impact score of 47.5112066080017 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Logan Wallace]

    Northwestern Mutual Wealth Management Co. grew its holdings in shares of Canadian National Railway (NYSE:CNI) (TSE:CNR) by 1.3% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 134,917 shares of the transportation company’s stock after acquiring an additional 1,692 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in Canadian National Railway were worth $11,030,000 at the end of the most recent quarter.

Leave a Reply

Your email address will not be published. Required fields are marked *